PRGX Global (PRGX) 10-Q 6 Nov 14 2014 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Sep. 30, 2014	Oct. 24, 2014
Document and Entity Information [Abstract]	'	'
Entity Registrant Name	'PRGX GLOBAL, INC.	'
Entity Central Index Key	'0001007330	'
Document Type	'10-Q	'
Document Period End Date	30-Sep-14	'
Amendment Flag	'false	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q3	'
Current Fiscal Year Focus	'--12-31	'
Entity Filer Category	'Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	27,251,061

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Income Statement [Abstract]	'	'	'	'
Revenue	$42,988	$53,403	$122,870	$148,709
Operating expenses:	'	'	'	'
Cost of revenue	28,681	31,803	87,457	95,863
Selling, general and administrative expenses	10,492	13,017	31,505	35,226
Depreciation of property and equipment	1,428	2,034	4,696	6,069
Amortization of intangible assets	895	1,204	2,700	3,812
Total operating expenses	41,496	48,058	126,358	140,970
Operating income (loss)	1,492	5,345	-3,488	7,739
Foreign currency transaction (gains) losses on short-term intercompany balances	1,221	-636	1,073	-54
Interest Income (Expense), Net	44	-75	33	89
Income (loss) before income taxes	315	5,906	-4,528	7,882
Income tax expense	554	1,029	853	1,671
Net income (loss)	($239)	$4,877	($5,381)	$6,211
Basic earnings (loss) per common share (usd per share)	($0.01)	$0.17	($0.18)	$0.21
Diluted earnings (loss) per common share (usd per share)	($0.01)	$0.16	($0.18)	$0.21
Weighted-average common shares outstanding:	'	'	'	'
Basic (shares)	27,744	29,396	29,203	29,075
Diluted (shares)	27,744	29,815	29,203	29,517

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]	'	'	'	'
Net income (loss)	($239)	$4,877	($5,381)	$6,211
Foreign currency translation adjustments	-619	96	-112	-933
Comprehensive income (loss)	($858)	$4,973	($5,493)	$5,278

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Current assets:	'	'
Cash and cash equivalents	$26,293	$43,700
Restricted cash	121	57
Contract receivables, less allowances of $2,089 in 2014 and $1,996 in 2013:	'	'
Billed	30,319	28,175
Unbilled	2,341	9,904
Receivables Net	32,660	38,079
Employee advances and miscellaneous receivables, less allowances of $549 in 2014 and $402 in 2013	1,343	2,242
Total receivables	34,003	40,321
Prepaid expenses and other current assets	4,591	3,917
Total current assets	65,008	87,995
Property and equipment	56,060	58,796
Less accumulated depreciation and amortization	-43,289	-44,802
Property and equipment, net	12,771	13,994
Goodwill	13,667	13,686
Intangible assets, less accumulated amortization of $35,231 in 2014 and $32,717 in 2013	10,862	13,582
Noncurrent portion of unbilled receivables	1,021	1,379
Other assets	2,500	2,193
Total assets	105,829	132,829
Current liabilities:	'	'
Accounts payable and accrued expenses	7,720	10,809
Accrued payroll and related expenses	14,776	15,415
Refund liabilities	5,611	6,597
Deferred revenue	1,213	1,512
Business acquisition obligations	0	3,156
Total current liabilities	29,320	37,489
Noncurrent refund liabilities	878	950
Other long-term liabilities	526	562
Total liabilities	30,724	39,001
Commitments and contingencies	'	'
Shareholders’ equity:	'	'
Common stock, no par value; $.01 stated value per share. Authorized 50,000,000 shares; 27,256,096 shares issued and outstanding as of September 30, 2014 and 29,367,439 shares issued and outstanding as of December 31, 2013	273	294
Additional paid-in capital	591,597	604,806
Accumulated deficit	-518,767	-513,386
Accumulated other comprehensive income	2,002	2,114
Total shareholders’ equity	75,105	93,828
Total liabilities and shareholders’ equity	$105,829	$132,829

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, except Share data, unless otherwise specified
Statement of Financial Position [Abstract]	'	'
Allowances for contract receivables	$2,089	$1,996
Allowances for employee advances and miscellaneous receivables	549	402
Accumulated amortization on intangible assets	$35,231	$32,717
Common stock, par value (usd per share)	$0	$0
Common stock, stated value per share (usd per share)	$0.01	$0.01
Common stock, shares authorized (shares)	50,000,000	50,000,000
Common stock, shares issued (shares)	27,256,096	29,367,439
Common stock, shares outstanding (shares)	27,256,096	29,367,439

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities:	'	'
Net income (loss)	($5,381)	$6,211
Adjustments to reconcile net income (loss) to net cash provided by operating activities:	'	'
Depreciation and amortization	7,396	9,881
Amortization of deferred loan costs	67	137
Stock-based compensation expense	3,409	3,777
Deferred income taxes	-933	115
Foreign currency transaction (gains) losses on short-term intercompany balances	1,073	-54
Changes in operating assets and liabilities:	'	'
Restricted cash	-64	-62
Billed receivables	-2,762	1,705
Unbilled receivables	7,921	216
Prepaid expenses and other current assets	541	-139
Other assets	15	24
Accounts payable and accrued expenses	-2,871	-4,001
Accrued payroll and related expenses	-445	-5,305
Refund liabilities	-1,058	-566
Deferred revenue	-265	-341
Noncurrent compensation obligations	414	285
Other long-term liabilities	73	-1,588
Net cash provided by operating activities	7,130	10,295
Cash flows from investing activities:	'	'
Purchases of property and equipment, net of disposal proceeds	-3,574	-4,544
Net cash used in investing activities	-3,574	-4,544
Cash flows from financing activities:	'	'
Repayments of long-term debt	0	-2,250
Payment of deferred loan costs	-104	0
Restricted stock repurchased from employees for withholding taxes	-568	-1,241
Proceeds from option exercises	2,790	611
Payments of deferred acquisition consideration	-2,208	-1,904
Net proceeds from issuance of common stock	0	4,118
Repurchase of common stock	-20,000	0
Net cash used in financing activities	-20,090	-666
Effect of exchange rates on cash and cash equivalents	-873	-484
Net (decrease) increase in cash and cash equivalents	-17,407	4,601
Cash and cash equivalents at beginning of period	43,700	37,806
Cash and cash equivalents at end of period	26,293	42,407
Supplemental disclosure of cash flow information:	'	'
Cash paid during the period for interest	80	488
Cash paid during the period for income taxes, net of refunds received	$2,405	$2,315

Basis_of_Presentation

Basis of Presentation	9 Months Ended
	Sep. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Basis of Presentation	'
	Basis of Presentation
	The accompanying Condensed Consolidated Financial Statements (Unaudited) of PRGX Global, Inc. and its wholly owned subsidiaries have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions for Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three-month and nine-month periods ended September 30, 2014 are not necessarily indicative of the results that may be expected for the year ending December 31, 2014.
	Except as otherwise indicated or unless the context otherwise requires, “PRGX,” “we,” “us,” “our” and the “Company” refer to PRGX Global, Inc. and its subsidiaries. For further information, refer to the Consolidated Financial Statements and Footnotes thereto included in the Company’s Form 10-K for the year ended December 31, 2013.
	Certain reclassifications have been made to the prior period financial statements, including the notes thereto, to conform to the presentation changes described below.
	Beginning with the second quarter of 2014, we reclassified certain information technology expenses within our Recovery Audit Services — Americas segment from Selling, General and Administrative expenses to Cost of Revenue to better reflect the nature of the work performed.
	Beginning with the first quarter of 2014, we present the former New Services segment as two separate segments: Adjacent Services, which was formerly referred to as Profit Optimization services, and Healthcare Claims Recovery Audit Services. We have revised the presentation of our operating segments and related information in Note D - Operating Segments and Related Information. Also beginning with the first quarter of 2014, we reclassified certain expenses within the Recovery Audit Services — Europe/Asia-Pacific segment from Cost of Revenue to Selling, General and Administrative expenses to better reflect costs associated with new business development efforts.
	Unbilled Receivables
	A significant portion of the unbilled receivables presented in the Condensed Consolidated Balance Sheets (Unaudited) related to our Healthcare Claims Recovery Audit Services as of December 31, 2013 as we generally cannot invoice the prime contractors for whom we operate as a subcontractor under the Medicare RAC program until cash is collected by the prime contractors. These unbilled receivables, net of the related reserves, were $5.6 million as of December 31, 2013. There were no unbilled receivables related to the Healthcare Claims Recovery Audit Services segment as of September 30, 2014.
	New Accounting Standards
	A summary of the new accounting standards issued by the Financial Accounting Standards Board (“FASB”) and included in the Accounting Standards Codification (“ASC”) that apply to PRGX is set forth below:
	FASB ASC Update No. 2014-15. In August 2014, the FASB issued Accounting Standards Update No. 2014-15, Presentation of Financial Statements—Going Concern (Subtopic 205-40) (“ASU 2014-15”). ASU 2014-15 provides guidance on management's responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and related disclosure requirements. ASU 2014-15 is effective for annual periods beginning after December 15, 2016 with early adoption permitted. We do not expect the adoption of ASU 2014-15 to have a material impact on our consolidated financial statements.
	FASB ASC Update No. 2014-09. In May 2014, the FASB issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASU 2014-09”). ASU 2014-09 supersedes the revenue recognition requirements in Revenue Recognition (Topic 605), and requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the transferring entity expects to be entitled to in exchange for those goods or services. ASU 2014-09 is effective for annual periods beginning after December 15, 2016. Early adoption is not permitted. We are currently undergoing an evaluation of the impact of ASU 2014-09 on our consolidated financial statements.
	FASB ASC Update No. 2014-08. In April 2014, the FASB issued Accounting Standards Update No. 2014-08, Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360)—Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity (“ASU 2014-08”). ASU 2014-08 raises the threshold for a disposal to qualify as a discontinued operation and requires new disclosures of both discontinued operations and certain other disposals that do not meet the definition of a discontinued operation. ASU 2014-08 is effective for annual periods beginning on or after December 15, 2014 with early adoption permitted for transactions that have not been disclosed in previously issued financial statements. We adopted ASU 2014-08 in the third quarter of 2014. The Company's disposal of assets on October 1, 2014 (see Note J) did not qualify as a discontinued operation as defined in ASU 2014-08. The impact of ASU 2014-08 on the Company's financial statements with respect to any future transaction will be dependent on whether any such transaction falls within the scope of the new guidance.

Earnings_Loss_Per_Common_Share

Earnings (Loss) Per Common Share	9 Months Ended
	Sep. 30, 2014
Earnings Per Share [Abstract]	'
Earnings (Loss) Per Common Share	'
	Earnings (Loss) Per Common Share
	The following tables set forth the computations of basic and diluted earnings (loss) per common share for the three and nine months ended September 30, 2014 and 2013 (in thousands, except per share data):
		Three Months Ended September 30,					Nine Months Ended September 30,
	Basic earnings (loss) per common share:	2014			2013		2014			2013
	Numerator:
	Net income (loss)	$	(239	)	$	4,877	$	(5,381	)	$	6,211
	Denominator:
	Weighted-average common shares outstanding	27,744			29,396		29,203			29,075
	Basic earnings (loss) per common share	$	(0.01	)	$	0.17	$	(0.18	)	$	0.21
		Three Months Ended September 30,					Nine Months Ended September 30,
	Diluted earnings (loss) per common share:	2014			2013		2014			2013
	Numerator:
	Net income (loss)	$	(239	)	$	4,877	$	(5,381	)	$	6,211
	Denominator:
	Weighted-average common shares outstanding	27,744			29,396		29,203			29,075
	Incremental shares from stock-based compensation plans	—			419		—			442
	Denominator for diluted earnings (loss) per common share	27,744			29,815		29,203			29,517
	Diluted earnings (loss) per common share	$	(0.01	)	$	0.16	$	(0.18	)	$	0.21
	Weighted-average shares outstanding excludes antidilutive shares underlying options that totaled 3.8 million shares and antidilutive Performance Units issuable under the Company's 2006 Management Incentive Plan that totaled less than 0.1 million shares from the computation of diluted earnings (loss) per common share for the three and nine months ended September 30, 2014. Weighted-average shares outstanding excludes antidilutive shares underlying options that totaled 1.6 million shares, and there were no antidilutive Performance Units related to the Company's 2006 Management Incentive Plan excluded from the computation of diluted earnings (loss) per common share for the three and nine months ended September 30, 2013. As a result of the net loss for the three and nine months ended September 30, 2014, all shares underlying stock options and Performance Units were considered antidilutive. The number of common shares we used in the basic and diluted earnings (loss) per common share computations include nonvested restricted shares of 0.6 million and 0.7 million for the three and nine months ended September 30, 2014 and 2013, respectively, and nonvested restricted share units that we consider to be participating securities of 0.1 million and 0.2 million for the three and nine months ended September 30, 2014 and 2013, respectively.
	On December 11, 2012, we closed a public offering of 6,249,234 shares of our common stock, which consisted of 2,500,000 shares sold by us and 3,749,234 shares sold by certain selling shareholders, at a price to the public of $6.39 per share. The net proceeds to us from the public offering, after deducting underwriting discounts and commissions and offering expenses, were $14.7 million. We did not receive any proceeds from the sale of shares by the selling shareholders. In addition, the underwriters elected to exercise an overallotment option for an additional 687,385 shares, and completed the additional sale on January 8, 2013. The net proceeds to us from the overallotment, after deducting underwriting discounts and commissions and offering expenses, were $4.1 million.
	In partial satisfaction of a business acquisition obligation, we issued 187,620 shares of our common stock having a value of $1.3 million in the nine months ended September 30, 2014 and 217,155 shares of our common stock having a value of $1.4 million in the nine months ended September 30, 2013.
	We repurchased 1,413,017 shares of our common stock during the three months ended September 30, 2014 for $9.0 million, and 3,117,277 shares of our common stock during the nine months ended September 30, 2014 for $20.0 million. There were no repurchases during the year ended December 31, 2013.
	Pursuant to exercises of outstanding stock options, we issued 710,063 shares of our common stock having a value of $2.8 million in the nine months ended September 30, 2014 and 129,976 shares of our common stock having a value of $0.6 million in the nine months ended September 30, 2013. Stock option exercises during the nine-month period ended September 30, 2014 primarily consisted of exercises by former executive officers of the Company.

StockBased_Compensation

Stock-Based Compensation	9 Months Ended
	Sep. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Stock-Based Compensation	'
	Stock-Based Compensation
	The Company currently has three stock-based compensation plans under which awards have been granted: (1) the Stock Incentive Plan; (2) the 2006 Management Incentive Plan (“2006 MIP”); and (3) the 2008 Equity Incentive Plan (“2008 EIP”) (collectively, the “Plans”). We describe the Plans in the Company’s Annual Report on Form 10–K for the fiscal year ended December 31, 2013.
	2008 EIP Awards
	Stock options granted under the 2008 EIP generally have a term of six to seven years and vest in equal annual increments over the vesting period, which typically is three years for employees and one year for directors. The following table summarizes stock option grants during the nine months ended September 30, 2014 and 2013:
	Grantee		# of	Vesting Period	Weighted		Weighted
	Type		Options		Average		Average Grant
			Granted		Exercise Price		Date Fair Value
	2014
	Director group		51,276	1 year or less	$	6.45	$	1.89
	Employee group (1)		1,480,000	3 years	$	6.99	$	1.81
	Employee inducement (2)		270,000	3 years	$	6.64	$	1.71
	2013
	Director group		75,490	1 year or less	$	5.67	$	2
	Director group		17,092	3 years	$	6.83	$	3.76
	Employee group		449,875	3 years	$	5.58	$	2.44
	Employee inducement (3)		20,000	3 years	$	7.14	$	3.81
	-1	The weighted average exercise price for these options is calculated based on an exercise price of $6.36 for the options that vest on June 27, 2015, $6.99 for the options that vest on June 27, 2016 and $7.63 for the options that vest on June 27, 2017.
	-2	The Company granted non-qualified stock options outside its existing stock-based compensation plans in the third quarter of 2014 to two executive officers in connection with the employees joining the Company. The weighted average exercise price for these options is calculated based on an exercise price of $6.04 for the options that vest on September 11, 2015, $6.64 for the options that vest on September 11, 2016 and $7.24 for the options that vest on September 11, 2017.
	-3	The Company granted non-qualified performance-based stock options outside its existing stock-based compensation plans in the first quarter of 2013 to one employee in connection with the employee joining the Company.
	Nonvested stock awards, including both restricted stock and restricted stock units, generally are nontransferable until vesting and the holders are entitled to receive dividends with respect to the nonvested shares. Prior to vesting, the grantees of restricted stock are entitled to vote the shares, but the grantees of restricted stock units are not entitled to vote the shares. Generally, nonvested stock awards vest in equal annual increments over the vesting period, which typically is three years for employees and one year for directors. The following table summarizes nonvested stock awards granted during the nine months ended September 30, 2014 and 2013:
	Grantee		# of Shares	Vesting Period	Weighted
	Type		Granted		Average Grant
					Date Fair Value
	2014
	Director group		51,276	1 year or less	$	6.45
	Employee group		120,000	3 years	$	6.36
	Employee inducement (1)		70,000	3 years	$	6.04
	2013
	Director group		75,490	1 year or less	$	5.67
	Director group		17,092	3 years	$	6.83
	Employee group		449,875	3 years	$	5.58
	Employee inducement (2)		20,000	3 years	$	7.14
	-1	The Company granted nonvested stock awards (restricted stock) outside its existing stock-based compensation plans in the third quarter of 2014 to two executive officers in connection with the employees joining the Company.
	-2	The Company granted nonvested performance-based stock awards (restricted stock) outside its existing stock-based compensation plans in the first quarter of 2013 to one employee in connection with the employee joining the Company.
	2006 MIP Performance Units
	On June 19, 2012, seven senior officers of the Company were granted 154,264 Performance Units under the 2006 MIP, comprising all of the then remaining available awards under the 2006 MIP. The awards had an aggregate grant date fair value of $1.2 million and vest ratably over three years. Upon vesting, the Performance Units will be settled by the issuance of Company common stock equal to 60% of the number of Performance Units being settled and the payment of cash in an amount equal to 40% of the fair market value of that number of shares of common stock equal to the number of Performance Units being settled. During the nine months ended September 30, 2014, an aggregate of 27,546 Performance Units were settled which resulted in the issuance of 16,526 shares of common stock and cash payments totaling $0.1 million. During the nine months ended September 30, 2013, an aggregate of 52,334 Performance Units were settled which resulted in the issuance of 31,399 shares of common stock and cash payments totaling $0.1 million. Since the June 19, 2012 grant date to September 30, 2014, an aggregate of 121,210 Performance Units were settled by three current executive officers and three former executive officers, and 16,524 Performance Units were forfeited by one former executive officer and currently are available to be granted. Such settlements resulted in the issuance of 69,438 shares of common stock and cash payments totaling $0.3 million from the grant date through September 30, 2014. As of September 30, 2014, a total of 16,530 Performance Units were outstanding, none of which were vested.
	Selling, general and administrative expenses for the three months ended September 30, 2014 and 2013 include $1.4 million and $1.3 million, respectively, related to stock-based compensation charges. Selling, general and administrative expenses for the nine months ended September 30, 2014 and 2013 include $3.4 million and $3.8 million, respectively, related to stock-based compensation charges. At September 30, 2014, there was $6.7 million of unrecognized stock-based compensation expense related to stock options, restricted stock awards, restricted stock unit awards, and Performance Unit awards which we expect to recognize over a weighted-average period of 2.2 years.

Operating_Segments_and_Related

Operating Segments and Related Information	9 Months Ended
	Sep. 30, 2014
Segment Reporting [Abstract]	'
Operating Segments and Related Information	'
	Operating Segments and Related Information
	Beginning with the first quarter of 2014, we present the former New Services segment as two separate segments: Adjacent Services, which was formerly referred to as Profit Optimization services, and Healthcare Claims Recovery Audit Services. We now conduct our operations through the following four reportable segments:
	Recovery Audit Services – Americas represents recovery audit services (other than Healthcare Claims Recovery Audit services) provided in the United States of America (“U.S.”), Canada and Latin America.
	Recovery Audit Services – Europe/Asia-Pacific represents recovery audit services (other than Healthcare Claims Recovery Audit services) provided in Europe, Asia and the Pacific region.
	Adjacent Services (formerly known as Profit Optimization services) represents data transformation and financial advisory services.
	Healthcare Claims Recovery Audit Services represents recovery audit services for healthcare claims, which consist primarily of services provided under subcontracts related to the Medicare Recovery Audit Contractor program.
	Additionally, Corporate Support includes the unallocated portion of corporate selling, general and administrative expenses not specifically attributable to the four reportable segments.
	We evaluate the performance of our reportable segments based upon revenue and measures of profit or loss we refer to as EBITDA and Adjusted EBITDA. We define Adjusted EBITDA as earnings from continuing operations before interest and taxes (“EBIT”), adjusted for depreciation and amortization (“EBITDA”), and then further adjusted for unusual and other significant items that management views as distorting the operating results of the various segments from period to period. Such adjustments include restructuring charges, stock-based compensation, bargain purchase gains, acquisition-related charges and benefits (acquisition transaction costs, acquisition obligations classified as compensation, and fair value adjustments to acquisition-related contingent consideration), tangible and intangible asset impairment charges, certain litigation costs and litigation settlements, certain severance charges and foreign currency transaction gains and losses on short-term intercompany balances viewed by management as individually or collectively significant. We do not have any inter-segment revenue.
	Segment information for the three and nine months ended September 30, 2013 has been revised to reflect the change in reportable segments. Segment information for the three and nine months ended September 30, 2014 and 2013 (in thousands) is as follows:
		Recovery			Recovery Audit			Adjacent			Healthcare Claims Recovery Audit Services			Corporate			Total
		Audit			Services –			Services						Support
		Services –			Europe/Asia-
		Americas			Pacific
	Three Months Ended September 30, 2014
	Revenue	$	28,550		$	10,708		$	3,586		$	144		$	—		$	42,988
	Net income (loss)																$	(239	)
	Income tax expense																554
	Interest expense (income), net																(44		)
	EBIT	$	7,155		$	(151	)	$	(265	)	$	(1,133	)	$	(5,335	)	271
	Depreciation of property and equipment	1,111			150			145			22			—			1,428
	Amortization of intangible assets	500			299			96			—			—			895
	EBITDA	8,766			298			(24		)	(1,111		)	(5,335		)	2,594
	Foreign currency transaction (gains) losses on short-term intercompany balances	208			1,192			—			—			(179		)	1,221
	Transformation severance and related expenses	44			7			18			26			318			413
	Stock-based compensation	—			—			—			—			1,405			1,405
	Adjusted EBITDA	$	9,018		$	1,497		$	(6	)	$	(1,085	)	$	(3,791	)	$	5,633
		Recovery			Recovery Audit			Adjacent			Healthcare Claims Recovery Audit Services			Corporate			Total
		Audit			Services –			Services						Support
		Services –			Europe/Asia-
		Americas			Pacific
	Three Months Ended September 30, 2013
	Revenue	$	32,365		$	12,009		$	3,625		$	5,404		$	—		$	53,403
	Net income (loss)																$	4,877
	Income tax expense																1,029
	Interest expense (income), net																75
	EBIT	$	9,418		$	1,987		$	(351	)	$	621		$	(5,694	)	5,981
	Depreciation of property and equipment	1,414			124			167			329			—			2,034
	Amortization of intangible assets	698			323			183			—			—			1,204
	EBITDA	11,530			2,434			(1		)	950			(5,694		)	9,219
	Foreign currency transaction (gains) losses on short-term intercompany balances	(80		)	(574		)	—			—			18			(636		)
	Acquisition-related charges (benefits)	662			—			44			—			—			706
	Transformation severance and related expenses	20			56			81			4			—			161
	Stock-based compensation	—			—			—			—			1,304			1,304
	Adjusted EBITDA	$	12,132		$	1,916		$	124		$	954		$	(4,372	)	$	10,754
		Recovery			Recovery Audit			Adjacent			Healthcare Claims Recovery Audit Services			Corporate			Total
		Audit			Services –			Services						Support
		Services –			Europe/Asia-
		Americas			Pacific
	Nine Months Ended September 30, 2014
	Revenue	$	80,377		$	32,792		$	8,150		$	1,551		$	—		$	122,870
	Net income (loss)																$	(5,381	)
	Income tax expense																853
	Interest expense (income), net																(33		)
	EBIT	$	16,632		$	1,309		$	(3,607	)	$	(4,785	)	$	(14,110	)	(4,561		)
	Depreciation of property and equipment	3,612			445			463			176			—			4,696
	Amortization of intangible assets	1,501			911			288			—			—			2,700
	EBITDA	21,745			2,665			(2,856		)	(4,609		)	(14,110		)	2,835
	Foreign currency transaction (gains) losses on short-term intercompany balances	164			1,079			—			—			(170		)	1,073
	Acquisition-related charges (benefits)	—			—			249			—			—			249
	Transformation severance and related expenses	510			569			396			431			446			2,352
	Stock-based compensation	—			—			—			—			3,409			3,409
	Adjusted EBITDA	$	22,419		$	4,313		$	(2,211	)	$	(4,178	)	$	(10,425	)	$	9,918
		Recovery			Recovery Audit			Adjacent			Healthcare Claims Recovery Audit Services			Corporate			Total
Audit			Services –			Services			Support
Services –			Europe/Asia-
Americas			Pacific
Nine Months Ended September 30, 2013
Revenue	$	87,999		$	33,796		$	10,705		$	16,209		$	—		$	148,709
Net income (loss)																$	6,211
Income tax expense																1,671
Interest expense (income), net																(89		)
EBIT	$	21,643		$	2,354		$	(1,998	)	$	1,476		$	(15,682	)	7,793
Depreciation of property and equipment	4,138			362			476			1,093			—			6,069
Amortization of intangible assets	2,094			1,171			547			—			—			3,812
EBITDA	27,875			3,887			(975		)	2,569			(15,682		)	17,674
Foreign currency transaction (gains) losses on short-term intercompany balances	143			(199		)	—			—			2			(54		)
Acquisition-related charges (benefits)	987			(900		)	144			—			—			231
Transformation severance and related expenses	100			593			81			4			—			778
Stock-based compensation	—			—			—			—			3,777			3,777
Adjusted EBITDA	$	29,105		$	3,381		$	(750	)	$	2,573		$	(11,903	)	$	22,406

Cash_and_Cash_Equivalents

Cash and Cash Equivalents	9 Months Ended
	Sep. 30, 2014
Cash and Cash Equivalents [Abstract]	'
Cash and Cash Equivalents	'
	Cash and Cash Equivalents
	Cash and cash equivalents include all cash balances and highly liquid investments with an initial maturity of three months or less from date of purchase. We place our temporary cash investments with high credit quality financial institutions. At times, certain investments may be in excess of the Federal Deposit Insurance Corporation (“FDIC”) insurance limit or otherwise may not be covered by FDIC insurance. Some of our cash and cash equivalents are held at banks in jurisdictions outside the U.S. that have restrictions on transferring such assets outside of these countries on a temporary or permanent basis. Such restricted net assets are not significant in comparison to our consolidated net assets.
	Our cash and cash equivalents included short-term investments of approximately $12.5 million as of September 30, 2014 and $24.6 million as of December 31, 2013, of which approximately $6.4 million and $4.4 million, respectively, were held at banks outside of the United States, primarily in Brazil and Canada.

Debt

Debt	9 Months Ended
	Sep. 30, 2014
Debt Disclosure [Abstract]	'
Debt	'
	Debt
	On January 19, 2010, we entered into a four-year revolving credit and term loan agreement with SunTrust Bank (“SunTrust”). The SunTrust credit facility initially consisted of a $15.0 million committed revolving credit facility and a $15.0 million term loan. The SunTrust term loan required quarterly principal payments of $0.8 million beginning in March 2010, and a final principal payment of $3.0 million due in January 2014 that we paid in December 2013. The SunTrust credit facility is guaranteed by the Company and all of its material domestic subsidiaries and secured by substantially all of the assets of the Company.
	On January 17, 2014, we entered into an amendment to the SunTrust credit facility that increased the committed revolving credit facility from $15.0 million to $25.0 million, lowered the applicable margin to a fixed rate of 1.75%, eliminated the provision limiting availability under the revolving credit facility based on eligible accounts receivable and extended the scheduled maturity of the revolving credit facility to January 16, 2015 (subject to earlier termination as provided therein). As of September 30, 2014, we had no outstanding borrowings under the SunTrust revolver. With the provision of a fixed applicable margin of 1.75% per the amendment of the SunTrust credit facility, the interest rate that would have applied at September 30, 2014 had any borrowings been outstanding was approximately 1.90%. We also must pay a commitment fee of 0.5% per annum, payable quarterly, on the unused portion of the SunTrust revolving credit facility.
	Prior to the January 2014 amendment to the SunTrust credit facility, amounts available under the SunTrust revolver were based on eligible accounts receivable and other factors. Interest on both the revolver and term loan was payable monthly and accrued at an index rate using the one-month LIBOR rate, plus an applicable margin as determined by the loan agreement. The applicable interest rate margin varied from 2.25% per annum to 3.5% per annum, dependent on our consolidated leverage ratio, and was determined in accordance with a pricing grid under the SunTrust loan agreement.
	The SunTrust credit facility, as amended, requires as of the end of each fiscal quarter, the Company to have achieved Consolidated Adjusted EBITDA (as defined in the agreement) of at least $18.0 million for the immediately preceding four quarters. As of June 30, 2014, the Company's Consolidated Adjusted EBITDA for the preceding four quarters was $17.0 million, and therefore the Company was not in compliance with the covenant, although there were no amounts outstanding under the credit facility as of that date. On August 7, 2014, the Company entered into an amendment of the SunTrust credit facility that provided a waiver of the non-compliance with the minimum Consolidated Adjusted EBITDA covenant for the quarter ended June 30, 2014, reduced the minimum Consolidated Adjusted EBITDA requirement to $12.0 million, modified the Fixed Charge Coverage Ratio definition for the quarter ending September 30, 2014 by excluding certain payments, and reduced the maximum borrowing amount under the senior credit facility to $20.0 million. The Company was in compliance with the covenants in its SunTrust credit facility as of September 30, 2014.

Fair_Value_of_Financial_Instru

Fair Value of Financial Instruments	9 Months Ended
	Sep. 30, 2014
Fair Value Disclosures [Abstract]	'
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments
	We state cash equivalents at cost, which approximates fair market value. The carrying values for receivables from clients, unbilled services, accounts payable, deferred revenue and other accrued liabilities reasonably approximate fair market value due to the nature of the financial instrument and the short term maturity of these items.
	We repaid the remaining balance of our bank debt in December 2013, and had no debt outstanding as of September 30, 2014. We consider the factors used in determining the fair value of debt to be Level 3 inputs (significant unobservable inputs).
	We had no business acquisition obligations as of September 30, 2014 and $3.2 million of business acquisition obligations as of December 31, 2013 representing the fair value of deferred consideration and earn-out payments estimated to be due as of those dates. We determine the estimated fair values based on our projections of future revenue and profits or other factors used in the calculation of the ultimate payment to be made. The discount rate that we use to value the liability is based on specific business risk, cost of capital, and other factors. We consider these factors to be Level 3 inputs (significant unobservable inputs).

Commitments_and_Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies	'
	Commitments and Contingencies
	Legal Proceedings
	We are party to a variety of legal proceedings arising in the normal course of business. While the results of these proceedings cannot be predicted with certainty, management believes that the final outcome of these proceedings will not have a material adverse effect on our financial position, results of operations or cash flows.

Income_Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2014
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	Income Taxes
	Reported income tax expense in each period primarily results from taxes on the income of foreign subsidiaries. The effective tax rates generally differ from the expected tax rate due primarily to the Company’s deferred tax asset valuation allowance on the domestic earnings and taxes on income of foreign subsidiaries.
	In the nine months ended September 30, 2013, we partially offset these foreign income taxes by reversing $0.5 million of accruals made in prior years for uncertain tax positions. Significant judgment is required in evaluating our uncertain tax positions and determining our provision for income taxes. In addition, we are subject to the continuous examination of our income tax returns by the Internal Revenue Service in the U.S. and other tax authorities. We regularly assess the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of our provision for income taxes.

Subsequent_Events

Subsequent Events	9 Months Ended
	Sep. 30, 2014
Subsequent Events [Abstract]	'
Subsequent Events	'
	Subsequent Events
	On October 1, 2014, the Company sold certain assets related to its Chicago, Illinois-based consulting business that were previously acquired in November 2010 from TJG Holdings LLC to Salo, LLC, a Minnesota limited liability company. The Company received an initial cash payment of $1.1 million in connection with the closing of the transaction and will receive payment for working capital transferred to the buyer. In addition, the Company may receive up to $0.9 million in earn-out payments based on certain revenue recognized by the buyer in relation to the acquired business during the year following the closing date.
	On October 24, 2014, our Board of Directors authorized a $20.0 million increase to the Company's stock repurchase program, increasing the total stock repurchase program since its inception to $40.0 million, and extended the duration of the program to December 31, 2015. From the February 2014 announcement of the Company’s current stock repurchase program through September 30, 2014, the Company has repurchased 3.1 million shares, or 10.4% of its common stock outstanding on the date of the announcement, for an aggregate cost of $20.0 million.

Basis_of_Presentation_Policies

Basis of Presentation (Policies)	9 Months Ended
	Sep. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Basis of Presentation	'
	Basis of Presentation
	The accompanying Condensed Consolidated Financial Statements (Unaudited) of PRGX Global, Inc. and its wholly owned subsidiaries have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions for Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three-month and nine-month periods ended September 30, 2014 are not necessarily indicative of the results that may be expected for the year ending December 31, 2014.
	Except as otherwise indicated or unless the context otherwise requires, “PRGX,” “we,” “us,” “our” and the “Company” refer to PRGX Global, Inc. and its subsidiaries. For further information, refer to the Consolidated Financial Statements and Footnotes thereto included in the Company’s Form 10-K for the year ended December 31, 2013.
	Certain reclassifications have been made to the prior period financial statements, including the notes thereto, to conform to the presentation changes described below.
	Beginning with the second quarter of 2014, we reclassified certain information technology expenses within our Recovery Audit Services — Americas segment from Selling, General and Administrative expenses to Cost of Revenue to better reflect the nature of the work performed.
	Beginning with the first quarter of 2014, we present the former New Services segment as two separate segments: Adjacent Services, which was formerly referred to as Profit Optimization services, and Healthcare Claims Recovery Audit Services. We have revised the presentation of our operating segments and related information in Note D - Operating Segments and Related Information. Also beginning with the first quarter of 2014, we reclassified certain expenses within the Recovery Audit Services — Europe/Asia-Pacific segment from Cost of Revenue to Selling, General and Administrative expenses to better reflect costs associated with new business development efforts.
Unbilled Receivables	'
	Unbilled Receivables
	A significant portion of the unbilled receivables presented in the Condensed Consolidated Balance Sheets (Unaudited) related to our Healthcare Claims Recovery Audit Services as of December 31, 2013 as we generally cannot invoice the prime contractors for whom we operate as a subcontractor under the Medicare RAC program until cash is collected by the prime contractors. These unbilled receivables, net of the related reserves, were $5.6 million as of December 31, 2013. There were no unbilled receivables related to the Healthcare Claims Recovery Audit Services segment as of September 30, 2014.
New Accounting Standards	'
	New Accounting Standards
	A summary of the new accounting standards issued by the Financial Accounting Standards Board (“FASB”) and included in the Accounting Standards Codification (“ASC”) that apply to PRGX is set forth below:
	FASB ASC Update No. 2014-15. In August 2014, the FASB issued Accounting Standards Update No. 2014-15, Presentation of Financial Statements—Going Concern (Subtopic 205-40) (“ASU 2014-15”). ASU 2014-15 provides guidance on management's responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern and related disclosure requirements. ASU 2014-15 is effective for annual periods beginning after December 15, 2016 with early adoption permitted. We do not expect the adoption of ASU 2014-15 to have a material impact on our consolidated financial statements.
	FASB ASC Update No. 2014-09. In May 2014, the FASB issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASU 2014-09”). ASU 2014-09 supersedes the revenue recognition requirements in Revenue Recognition (Topic 605), and requires an entity to recognize revenue when it transfers promised goods or services to customers in an amount that reflects the consideration to which the transferring entity expects to be entitled to in exchange for those goods or services. ASU 2014-09 is effective for annual periods beginning after December 15, 2016. Early adoption is not permitted. We are currently undergoing an evaluation of the impact of ASU 2014-09 on our consolidated financial statements.
	FASB ASC Update No. 2014-08. In April 2014, the FASB issued Accounting Standards Update No. 2014-08, Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360)—Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity (“ASU 2014-08”). ASU 2014-08 raises the threshold for a disposal to qualify as a discontinued operation and requires new disclosures of both discontinued operations and certain other disposals that do not meet the definition of a discontinued operation. ASU 2014-08 is effective for annual periods beginning on or after December 15, 2014 with early adoption permitted for transactions that have not been disclosed in previously issued financial statements. We adopted ASU 2014-08 in the third quarter of 2014. The Company's disposal of assets on October 1, 2014 (see Note J) did not qualify as a discontinued operation as defined in ASU 2014-08. The impact of ASU 2014-08 on the Company's financial statements with respect to any future transaction will be dependent on whether any such transaction falls within the scope of the new guidance.

Earnings_Loss_Per_Common_Share1

Earnings (Loss) Per Common Share (Tables)	9 Months Ended
	Sep. 30, 2014
Earnings Per Share [Abstract]	'
Computations of basic and diluted earnings (loss) per common share	'
	The following tables set forth the computations of basic and diluted earnings (loss) per common share for the three and nine months ended September 30, 2014 and 2013 (in thousands, except per share data):
		Three Months Ended September 30,					Nine Months Ended September 30,
	Basic earnings (loss) per common share:	2014			2013		2014			2013
	Numerator:
	Net income (loss)	$	(239	)	$	4,877	$	(5,381	)	$	6,211
	Denominator:
	Weighted-average common shares outstanding	27,744			29,396		29,203			29,075
	Basic earnings (loss) per common share	$	(0.01	)	$	0.17	$	(0.18	)	$	0.21
		Three Months Ended September 30,					Nine Months Ended September 30,
	Diluted earnings (loss) per common share:	2014			2013		2014			2013
	Numerator:
	Net income (loss)	$	(239	)	$	4,877	$	(5,381	)	$	6,211
	Denominator:
	Weighted-average common shares outstanding	27,744			29,396		29,203			29,075
	Incremental shares from stock-based compensation plans	—			419		—			442
	Denominator for diluted earnings (loss) per common share	27,744			29,815		29,203			29,517
	Diluted earnings (loss) per common share	$	(0.01	)	$	0.16	$	(0.18	)	$	0.21

StockBased_Compensation_Tables

Stock-Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Summary of stock option grants	'
	The following table summarizes stock option grants during the nine months ended September 30, 2014 and 2013:
	Grantee		# of	Vesting Period	Weighted		Weighted
	Type		Options		Average		Average Grant
			Granted		Exercise Price		Date Fair Value
	2014
	Director group		51,276	1 year or less	$	6.45	$	1.89
	Employee group (1)		1,480,000	3 years	$	6.99	$	1.81
	Employee inducement (2)		270,000	3 years	$	6.64	$	1.71
	2013
	Director group		75,490	1 year or less	$	5.67	$	2
	Director group		17,092	3 years	$	6.83	$	3.76
	Employee group		449,875	3 years	$	5.58	$	2.44
	Employee inducement (3)		20,000	3 years	$	7.14	$	3.81
	-1	The weighted average exercise price for these options is calculated based on an exercise price of $6.36 for the options that vest on June 27, 2015, $6.99 for the options that vest on June 27, 2016 and $7.63 for the options that vest on June 27, 2017.
	-2	The Company granted non-qualified stock options outside its existing stock-based compensation plans in the third quarter of 2014 to two executive officers in connection with the employees joining the Company. The weighted average exercise price for these options is calculated based on an exercise price of $6.04 for the options that vest on September 11, 2015, $6.64 for the options that vest on September 11, 2016 and $7.24 for the options that vest on September 11, 2017.
	-3	The Company granted non-qualified performance-based stock options outside its existing stock-based compensation plans in the first quarter of 2013 to one employee in connection with the employee joining the Company.
Summary of nonvested stock awards granted	'
	The following table summarizes nonvested stock awards granted during the nine months ended September 30, 2014 and 2013:
	Grantee		# of Shares	Vesting Period	Weighted
	Type		Granted		Average Grant
					Date Fair Value
	2014
	Director group		51,276	1 year or less	$	6.45
	Employee group		120,000	3 years	$	6.36
	Employee inducement (1)		70,000	3 years	$	6.04
	2013
	Director group		75,490	1 year or less	$	5.67
	Director group		17,092	3 years	$	6.83
	Employee group		449,875	3 years	$	5.58
	Employee inducement (2)		20,000	3 years	$	7.14
	-1	The Company granted nonvested stock awards (restricted stock) outside its existing stock-based compensation plans in the third quarter of 2014 to two executive officers in connection with the employees joining the Company.
	-2	The Company granted nonvested performance-based stock awards (restricted stock) outside its existing stock-based compensation plans in the first quarter of 2013 to one employee in connection with the employee joining the Company.

Operating_Segments_and_Related1

Operating Segments and Related Information (Tables)	9 Months Ended
	Sep. 30, 2014
Segment Reporting [Abstract]	'
Segment information	'
	Segment information for the three and nine months ended September 30, 2013 has been revised to reflect the change in reportable segments. Segment information for the three and nine months ended September 30, 2014 and 2013 (in thousands) is as follows:
		Recovery			Recovery Audit			Adjacent			Healthcare Claims Recovery Audit Services			Corporate			Total
		Audit			Services –			Services						Support
		Services –			Europe/Asia-
		Americas			Pacific
	Three Months Ended September 30, 2014
	Revenue	$	28,550		$	10,708		$	3,586		$	144		$	—		$	42,988
	Net income (loss)																$	(239	)
	Income tax expense																554
	Interest expense (income), net																(44		)
	EBIT	$	7,155		$	(151	)	$	(265	)	$	(1,133	)	$	(5,335	)	271
	Depreciation of property and equipment	1,111			150			145			22			—			1,428
	Amortization of intangible assets	500			299			96			—			—			895
	EBITDA	8,766			298			(24		)	(1,111		)	(5,335		)	2,594
	Foreign currency transaction (gains) losses on short-term intercompany balances	208			1,192			—			—			(179		)	1,221
	Transformation severance and related expenses	44			7			18			26			318			413
	Stock-based compensation	—			—			—			—			1,405			1,405
	Adjusted EBITDA	$	9,018		$	1,497		$	(6	)	$	(1,085	)	$	(3,791	)	$	5,633
		Recovery			Recovery Audit			Adjacent			Healthcare Claims Recovery Audit Services			Corporate			Total
		Audit			Services –			Services						Support
		Services –			Europe/Asia-
		Americas			Pacific
	Three Months Ended September 30, 2013
	Revenue	$	32,365		$	12,009		$	3,625		$	5,404		$	—		$	53,403
	Net income (loss)																$	4,877
	Income tax expense																1,029
	Interest expense (income), net																75
	EBIT	$	9,418		$	1,987		$	(351	)	$	621		$	(5,694	)	5,981
	Depreciation of property and equipment	1,414			124			167			329			—			2,034
	Amortization of intangible assets	698			323			183			—			—			1,204
	EBITDA	11,530			2,434			(1		)	950			(5,694		)	9,219
	Foreign currency transaction (gains) losses on short-term intercompany balances	(80		)	(574		)	—			—			18			(636		)
	Acquisition-related charges (benefits)	662			—			44			—			—			706
	Transformation severance and related expenses	20			56			81			4			—			161
	Stock-based compensation	—			—			—			—			1,304			1,304
	Adjusted EBITDA	$	12,132		$	1,916		$	124		$	954		$	(4,372	)	$	10,754
		Recovery			Recovery Audit			Adjacent			Healthcare Claims Recovery Audit Services			Corporate			Total
		Audit			Services –			Services						Support
		Services –			Europe/Asia-
		Americas			Pacific
	Nine Months Ended September 30, 2014
	Revenue	$	80,377		$	32,792		$	8,150		$	1,551		$	—		$	122,870
	Net income (loss)																$	(5,381	)
	Income tax expense																853
	Interest expense (income), net																(33		)
	EBIT	$	16,632		$	1,309		$	(3,607	)	$	(4,785	)	$	(14,110	)	(4,561		)
	Depreciation of property and equipment	3,612			445			463			176			—			4,696
	Amortization of intangible assets	1,501			911			288			—			—			2,700
	EBITDA	21,745			2,665			(2,856		)	(4,609		)	(14,110		)	2,835
	Foreign currency transaction (gains) losses on short-term intercompany balances	164			1,079			—			—			(170		)	1,073
	Acquisition-related charges (benefits)	—			—			249			—			—			249
	Transformation severance and related expenses	510			569			396			431			446			2,352
	Stock-based compensation	—			—			—			—			3,409			3,409
	Adjusted EBITDA	$	22,419		$	4,313		$	(2,211	)	$	(4,178	)	$	(10,425	)	$	9,918
		Recovery			Recovery Audit			Adjacent			Healthcare Claims Recovery Audit Services			Corporate			Total
		Audit			Services –			Services						Support
		Services –			Europe/Asia-
		Americas			Pacific
	Nine Months Ended September 30, 2013
	Revenue	$	87,999		$	33,796		$	10,705		$	16,209		$	—		$	148,709
	Net income (loss)																$	6,211
	Income tax expense																1,671
	Interest expense (income), net																(89		)
EBIT	$	21,643		$	2,354		$	(1,998	)	$	1,476		$	(15,682	)	7,793
Depreciation of property and equipment	4,138			362			476			1,093			—			6,069
Amortization of intangible assets	2,094			1,171			547			—			—			3,812
EBITDA	27,875			3,887			(975		)	2,569			(15,682		)	17,674
Foreign currency transaction (gains) losses on short-term intercompany balances	143			(199		)	—			—			2			(54		)
Acquisition-related charges (benefits)	987			(900		)	144			—			—			231
Transformation severance and related expenses	100			593			81			4			—			778
Stock-based compensation	—			—			—			—			3,777			3,777
Adjusted EBITDA	$	29,105		$	3,381		$	(750	)	$	2,573		$	(11,903	)	$	22,406

Basis_of_Presentation_Details

Basis of Presentation (Details) (USD $)	Dec. 31, 2013	Sep. 30, 2014
In Millions, unless otherwise specified	Medicare RAC [Member]	New Services [Member]
		segment
Accounts, Notes, Loans and Financing Receivable [Line Items]	'	'
Number of segments	'	2
Unbilled receivables, net of related reserves	$5.60	'

Earnings_Loss_Per_Common_Share2

Earnings (Loss) Per Common Share (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Numerator:	'	'	'	'
Net income (loss)	($239)	$4,877	($5,381)	$6,211
Denominator:	'	'	'	'
Weighted-average common shares outstanding (shares)	27,744	29,396	29,203	29,075
Basic earnings (loss) per common share (in dollars per share)	($0.01)	$0.17	($0.18)	$0.21
Numerator:	'	'	'	'
Net income (loss)	($239)	$4,877	($5,381)	$6,211
Denominator:	'	'	'	'
Weighted-average common shares outstanding (shares)	27,744	29,396	29,203	29,075
Incremental shares from stock-based compensation plans (shares)	0	419	0	442
Denominator for diluted earnings (loss) per common share (shares)	27,744	29,815	29,203	29,517
Diluted earnings (loss) per common share (in dollars per share)	($0.01)	$0.16	($0.18)	$0.21

Earnings_Loss_Per_Common_Share3

Earnings (Loss) Per Common Share (Details Textual) (USD $)	0 Months Ended		3 Months Ended		8 Months Ended	9 Months Ended
	Jan. 08, 2013	Dec. 11, 2012	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2013
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share and Other Significant Changes in Shares [Line Items]	'	'	'	'	'	'	'
Number of common shares in the basic and diluted earnings per common share (shares)	'	'	600,000	700,000	'	600,000	700,000
Nonvested restricted share (shares)	'	'	100,000	200,000	'	100,000	200,000
Public offering common stock shares (shares)	'	6,249,234	'	'	'	'	'
Public offering by company (shares)	'	2,500,000	'	'	'	'	'
Public offering by selling shareholders (shares)	'	3,749,234	'	'	'	'	'
Public offering, price per share (usd per share)	'	$6.39	'	'	'	'	'
Public offering, net proceeds	$4,100,000	$14,700,000	'	'	'	$0	$4,118,000
Additional shares, overallotment option (shares)	687,385	'	'	'	'	'	'
Stock Issued During Period, Shares, Other	'	'	'	'	'	710,063	129,976
Proceeds from Stock Options Exercised	'	'	'	'	'	2,790,000	611,000
Stock repurchased during period (in shares)	'	'	1,413,017	'	3,100,000	3,117,277	'
Stock repurchased during period, amount	'	'	9,000,000	'	20,000,000	20,000,000	'
Business Strategy, Inc. [Member]	'	'	'	'	'	'	'
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share and Other Significant Changes in Shares [Line Items]	'	'	'	'	'	'	'
Business combination, consideration paid in common stock, shares	'	'	'	'	'	187,620	217,155
Business combination, consideration paid in common stock, value	'	'	'	'	'	$1,300,000	$1,400,000
Non-qualified Option [Member]	'	'	'	'	'	'	'
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share and Other Significant Changes in Shares [Line Items]	'	'	'	'	'	'	'
Weighted average shares outstanding excludes anti-dilutive shares underlying options (shares) (less than 0.1 million)	'	'	3,800,000	1,600,000	'	3,800,000	1,600,000
Performance Unit [Member]	'	'	'	'	'	'	'
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share and Other Significant Changes in Shares [Line Items]	'	'	'	'	'	'	'
Weighted average shares outstanding excludes anti-dilutive shares underlying options (shares) (less than 0.1 million)	'	'	100,000	0	'	100,000	0

StockBased_Compensation_Detail

Stock-Based Compensation (Details) (USD $)	9 Months Ended
	Sep. 30, 2014		Sep. 30, 2013
Director group [Member] | Equity Incentive Plan Year [Member]	'		'
Summary of stock option grants	'		'
Grantee Type	'Director group		'Director group
No. of Options Granted (shares)	51,276		75,490
Vesting Period	'1 year or less		'1 year or less
Weighted Average Exercise Price (usd per share)	$6.45		$5.67
Weighted Average Grant Date Fair Value (usd per share)	$1.89		$2
Director Group 1 [Member] | Equity Incentive Plan Year [Member]	'		'
Summary of stock option grants	'		'
Grantee Type	'		'Director group
No. of Options Granted (shares)	'		17,092
Vesting Period	'		'3 years
Weighted Average Exercise Price (usd per share)	'		$6.83
Weighted Average Grant Date Fair Value (usd per share)	'		$3.76
Employee [Member] | Equity Incentive Plan Year [Member]	'		'
Summary of stock option grants	'		'
Grantee Type	'Employee group (1)	[1]	'Employee group
No. of Options Granted (shares)	1,480,000	[1]	449,875
Vesting Period	'3 years	[1]	'3 years
Weighted Average Exercise Price (usd per share)	$6.99	[1]	$5.58
Weighted Average Grant Date Fair Value (usd per share)	$1.81	[1]	$2.44
Employee [Member] | Equity Incentive Plan Year [Member] | Year One [Member]	'		'
Summary of stock option grants	'		'
Weighted Average Exercise Price (usd per share)	$6.36	[1]	'
Employee [Member] | Equity Incentive Plan Year [Member] | Year Two [Member]	'		'
Summary of stock option grants	'		'
Weighted Average Exercise Price (usd per share)	$6.99	[1]	'
Employee [Member] | Equity Incentive Plan Year [Member] | Year Three [Member]	'		'
Summary of stock option grants	'		'
Weighted Average Exercise Price (usd per share)	$7.63	[1]	'
Employee [Member] | Employee Inducement [Member] | Year One [Member]	'		'
Summary of stock option grants	'		'
Weighted Average Exercise Price (usd per share)	$6.04	[2]	'
Employee [Member] | Employee Inducement [Member] | Year Two [Member]	'		'
Summary of stock option grants	'		'
Weighted Average Exercise Price (usd per share)	$6.64	[2]	'
Employee [Member] | Employee Inducement [Member] | Year Three [Member]	'		'
Summary of stock option grants	'		'
Weighted Average Exercise Price (usd per share)	$7.24	[2]	'
Employee inducement [Member] | Equity Incentive Plan Year [Member]	'		'
Summary of stock option grants	'		'
Grantee Type	'Employee inducement (2)	[2]	'Employee inducement (3)	[3]
No. of Options Granted (shares)	270,000	[2]	20,000	[3]
Vesting Period	'3 years	[2]	'3 years	[3]
Weighted Average Exercise Price (usd per share)	$6.64	[2]	$7.14	[3]
Weighted Average Grant Date Fair Value (usd per share)	$1.71	[2]	$3.81	[3]
[1]	The weighted average exercise price for these options is calculated based on an exercise price of $6.36 for the options that vest on June 27, 2015, $6.99 for the options that vest on June 27, 2016 and $7.63 for the options that vest on June 27, 2017.
[2]	The Company granted non-qualified stock options outside its existing stock-based compensation plans in the third quarter of 2014 to two executive officers in connection with the employees joining the Company. The weighted average exercise price for these options is calculated based on an exercise price of $6.04 for the options that vest on September 11, 2015, $6.64 for the options that vest on
[3]	The Company granted non-qualified performance-based stock options outside its existing stock-based compensation plans in the first quarter of 2013 to one employee in connection with the employee joining the Company.

StockBased_Compensation_Detail1

Stock-Based Compensation (Details 1) (USD $)	9 Months Ended
	Sep. 30, 2014		Sep. 30, 2013
2008 Equity Incentive Plan [Member] | Director group [Member]	'		'
Summary of nonvested stock awards granted	'		'
Vesting Period	'1 year or less		'1 year or less
Weighted Average Grant Date Fair Value (usd per share)	$1.89		$2
2008 Equity Incentive Plan [Member] | Director Group 1 [Member]	'		'
Summary of nonvested stock awards granted	'		'
Vesting Period	'		'3 years
Weighted Average Grant Date Fair Value (usd per share)	'		$3.76
2008 Equity Incentive Plan [Member] | Employee [Member]	'		'
Summary of nonvested stock awards granted	'		'
Vesting Period	'3 years	[1]	'3 years
Weighted Average Grant Date Fair Value (usd per share)	$1.81	[1]	$2.44
2008 Equity Incentive Plan [Member] | Employee inducement [Member]	'		'
Summary of nonvested stock awards granted	'		'
Vesting Period	'3 years	[2]	'3 years	[3]
Weighted Average Grant Date Fair Value (usd per share)	$1.71	[2]	$3.81	[3]
Restricted Stock and Restricted Stock Units [Member] | Director group [Member]	'		'
Summary of nonvested stock awards granted	'		'
Vesting Period	'1 year		'
Restricted Stock and Restricted Stock Units [Member] | Employee [Member]	'		'
Summary of nonvested stock awards granted	'		'
Vesting Period	'3 years		'
Restricted Stock and Restricted Stock Units [Member] | 2008 Equity Incentive Plan [Member] | Director group [Member]	'		'
Summary of nonvested stock awards granted	'		'
Grantee Type	'Director group		'Director group
No. of Shares Granted (shares)	51,276		75,490
Vesting Period	'1 year or less		'1 year or less
Weighted Average Grant Date Fair Value (usd per share)	$6.45		$5.67
Restricted Stock and Restricted Stock Units [Member] | 2008 Equity Incentive Plan [Member] | Director Group 1 [Member]	'		'
Summary of nonvested stock awards granted	'		'
Grantee Type	'		'Director group
No. of Shares Granted (shares)	'		17,092
Vesting Period	'		'3 years
Weighted Average Grant Date Fair Value (usd per share)	'		$6.83
Restricted Stock and Restricted Stock Units [Member] | 2008 Equity Incentive Plan [Member] | Employee [Member]	'		'
Summary of nonvested stock awards granted	'		'
Grantee Type	'Employee group		'Employee group
No. of Shares Granted (shares)	120,000		449,875
Vesting Period	'3 years		'3 years
Weighted Average Grant Date Fair Value (usd per share)	$6.36		$5.58
Restricted Stock and Restricted Stock Units [Member] | 2008 Equity Incentive Plan [Member] | Employee inducement [Member]	'		'
Summary of nonvested stock awards granted	'		'
Grantee Type	'Employee inducement (1)	[4]	'Employee inducement (2)	[5]
No. of Shares Granted (shares)	70,000	[4]	20,000	[5]
Vesting Period	'3 years	[4]	'3 years	[5]
Weighted Average Grant Date Fair Value (usd per share)	$6.04	[4]	$7.14	[5]
[1]	The weighted average exercise price for these options is calculated based on an exercise price of $6.36 for the options that vest on June 27, 2015, $6.99 for the options that vest on June 27, 2016 and $7.63 for the options that vest on June 27, 2017.
[2]	The Company granted non-qualified stock options outside its existing stock-based compensation plans in the third quarter of 2014 to two executive officers in connection with the employees joining the Company. The weighted average exercise price for these options is calculated based on an exercise price of $6.04 for the options that vest on September 11, 2015, $6.64 for the options that vest on
[3]	The Company granted non-qualified performance-based stock options outside its existing stock-based compensation plans in the first quarter of 2013 to one employee in connection with the employee joining the Company.
[4]	The Company granted nonvested stock awards (restricted stock) outside its existing stock-based compensation plans in the third quarter of 2014 to two executive officers in connection with the employees joining the Company.
[5]	The Company granted nonvested performance-based stock awards (restricted stock) outside its existing stock-based compensation plans in the first quarter of 2013 to one employee in connection with the employee joining the Company.

StockBased_Compensation_Detail2

Stock-Based Compensation (Details Textual) (USD $)

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

0 Months Ended

3 Months Ended

6 Months Ended

9 Months Ended

In Millions, except Share data, unless otherwise specified

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Mar. 31, 2013

Sep. 30, 2014

Sep. 30, 2013

Jun. 19, 2012

Sep. 30, 2014

Jun. 30, 2013

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

compensation_plan

The Plans [Member]

The Plans [Member]

The Plans [Member]

The Plans [Member]

Employee Group [Member]

Employee Group [Member]

Director Group [Member]

Director Group [Member]

Employee Inducement [Member]

Employee Inducement [Member]

Employee Inducement [Member]

Performance Shares [Member]

Performance Shares [Member]

Performance Shares [Member]

Performance Shares [Member]

Restricted Stock and Restricted Stock Units [Member]

Restricted Stock and Restricted Stock Units [Member]

Restricted Stock and Restricted Stock Units [Member]

Restricted Stock and Restricted Stock Units [Member]

Restricted Stock and Restricted Stock Units [Member]

Restricted Stock and Restricted Stock Units [Member]

Restricted Stock and Restricted Stock Units [Member]

Restricted Stock and Restricted Stock Units [Member]

Restricted Stock and Restricted Stock Units [Member]

Stock Options [Member]

Stock Options [Member]

Stock Options [Member]

Stock Options [Member]

Stock Options [Member]

Year One [Member]

Year One [Member]

Year Two [Member]

Year Two [Member]

Year Three [Member]

Year Three [Member]

2008 Equity Incentive Plan [Member]

2008 Equity Incentive Plan [Member]

2008 Equity Incentive Plan [Member]

2008 Equity Incentive Plan [Member]

2008 Equity Incentive Plan [Member]

2008 Equity Incentive Plan [Member]

2008 Equity Incentive Plan [Member]

2006 Management Incentive Plan [Member]

2006 Management Incentive Plan [Member]

2006 Management Incentive Plan [Member]

2006 Management Incentive Plan [Member]

2008 Equity Incentive Plan [Member]

Employee Group [Member]

Employee Group [Member]

Employee Group [Member]

Director Group [Member]

Director Group [Member]

Director Group [Member]

Employee Inducement [Member]

Employee Inducement [Member]

2008 Equity Incentive Plan [Member]

2008 Equity Incentive Plan [Member]

2008 Equity Incentive Plan [Member]

Employee Group [Member]

Director Group [Member]

Employee Group [Member]

Employee Group [Member]

Employee Group [Member]

Employee Group [Member]

Employee Group [Member]

Employee Group [Member]

employee

employee

officer

executive_officer

2008 Equity Incentive Plan [Member]

2008 Equity Incentive Plan [Member]

2008 Equity Incentive Plan [Member]

2008 Equity Incentive Plan [Member]

2008 Equity Incentive Plan [Member]

2008 Equity Incentive Plan [Member]

Minimum [Member]

Maximum [Member]

2008 Equity Incentive Plan [Member]

Employee Inducement [Member]

2008 Equity Incentive Plan [Member]

Employee Inducement [Member]

2008 Equity Incentive Plan [Member]

Employee Inducement [Member]

employee

employee

Stock-Based Compensation (Textual) [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of shares granted

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

120,000

449,875

'

51,276

75,490

70,000

[1]

20,000

[2]

'

'

'

'

'

'

'

'

'

'

'

Number of stock-based compensation plans

3

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock options expiration period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'6 years

'7 years

'

'

'

'

'

'

'

'

Stock options vesting period

'

'

'

'

'

'3 years

[3]

'3 years

'

'

'

'3 years

[4]

'3 years

[5]

'3 years

'

'

'

'

'3 years

'3 years

'3 years

'1 year

'

'

'3 years

[1]

'3 years

[2]

'

'

'

'3 years

'1 year

'

'

'

'

'

'

Stock options award vesting right

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'vest in equal annual increments over the vesting period

'

'

'

'

'

'

'

'

'vest in equal annual increments over the vesting period

'

'

'

'

'

'

'

'

'

'

Number of stock options granted (shares)

'

'

'

'

'

'

'

'

'

1

[5]

2

[4]

'

'

'

'

'

'

'

'

'

'

'

'

2

[1]

1

[2]

'

'

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

'

'

'

'

'

$6.99

[3]

$5.58

$6.45

$5.67

'

$6.64

[4]

$7.14

[5]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$6.36

[3]

$6.04

[4]

$6.99

[3]

$6.64

[4]

$7.63

[3]

$7.24

[4]

Number of officers

'

'

'

'

'

'

'

'

'

'

'

'

7

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Total of performance units were outstanding and fully vested (shares)

'

'

'

'

'

'

'

'

'

'

'

'

154,264

16,530

'

16,530

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Grant date fair value awards

'

'

'

'

'

'

'

'

'

'

'

'

$1.20

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Percentage of performance units (percent)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

60.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Percentage of fair market value (percent)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

40.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Performance units settled in period (shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

121,210

52,334

27,546

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common stock issued during period (shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

69,438

31,399

16,526

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Cash payments for shares settled during period

'

'

'

'

'

'

'

'

'

'

'

'

'

0.3

0.1

0.1

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of executive officers that settled performance units in period (executive officers)

'

'

'

'

'

'

'

'

'

'

'

'

'

3

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of former executive officers that settled performance units in period (executive officers)

'

'

'

'

'

'

'

'

'

'

'

'

'

3

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Performance units forfeited in period (shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

16,524

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of former executive officers that forfeited performance units in period (executive officer)

'

'

'

'

'

'

'

'

'

'

'

'

'

1

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Selling, general and administrative expenses

'

1.4

1.3

3.4

3.8

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Unrecognized stock-based compensation expense related to stock options

'

$6.70

'

$6.70

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Weighted-average period for recognizing stock compensation expense

'

'

'

'2 years 0 months 84 days

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

[1]

The Company granted nonvested stock awards (restricted stock) outside its existing stock-based compensation plans in the third quarter of 2014 to two executive officers in connection with the employees joining the Company.

[2]

The Company granted nonvested performance-based stock awards (restricted stock) outside its existing stock-based compensation plans in the first quarter of 2013 to one employee in connection with the employee joining the Company.

[3]

The weighted average exercise price for these options is calculated based on an exercise price of $6.36 for the options that vest on June 27, 2015, $6.99 for the options that vest on June 27, 2016 and $7.63 for the options that vest on June 27, 2017.

[4]

The Company granted non-qualified stock options outside its existing stock-based compensation plans in the third quarter of 2014 to two executive officers in connection with the employees joining the Company. The weighted average exercise price for these options is calculated based on an exercise price of $6.04 for the options that vest on September 11, 2015, $6.64 for the options that vest on

[5]

The Company granted non-qualified performance-based stock options outside its existing stock-based compensation plans in the first quarter of 2013 to one employee in connection with the employee joining the Company.

Operating_Segments_and_Related2

Operating Segments and Related Information (Details Textual)	9 Months Ended
	Sep. 30, 2014
	segment
Segment Reporting Information [Line Items]	'
Number of reportable segments	4
New Services [Member]	'
Segment Reporting Information [Line Items]	'
Number of reportable segments	2

Operating_Segments_and_Related3

Operating Segments and Related Information (Details) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Segment information	'	'	'	'
Revenue	$42,988	$53,403	$122,870	$148,709
Net income (loss)	-239	4,877	-5,381	6,211
Income tax expense	554	1,029	853	1,671
Interest expense (income), net	-44	75	-33	-89
EBIT	271	5,981	-4,561	7,793
Depreciation of property and equipment	1,428	2,034	4,696	6,069
Amortization of intangible assets	895	1,204	2,700	3,812
EBITDA	2,594	9,219	2,835	17,674
Foreign currency transaction (gains) losses on short-term intercompany balances	1,221	-636	1,073	-54
Acquisition-related charges (benefits)	'	706	249	231
Transformation severance and related expenses	413	161	2,352	778
Stock-based compensation	1,405	1,304	3,409	3,777
Adjusted EBITDA	5,633	10,754	9,918	22,406
Recovery Audit Services - Americas [Member]	'	'	'	'
Segment information	'	'	'	'
Revenue	28,550	32,365	80,377	87,999
EBIT	7,155	9,418	16,632	21,643
Depreciation of property and equipment	1,111	1,414	3,612	4,138
Amortization of intangible assets	500	698	1,501	2,094
EBITDA	8,766	11,530	21,745	27,875
Foreign currency transaction (gains) losses on short-term intercompany balances	208	-80	164	143
Acquisition-related charges (benefits)	'	662	'	987
Transformation severance and related expenses	44	20	510	100
Adjusted EBITDA	9,018	12,132	22,419	29,105
Recovery Audit Services - Europe/Asia-Pacific [Member]	'	'	'	'
Segment information	'	'	'	'
Revenue	10,708	12,009	32,792	33,796
EBIT	-151	1,987	1,309	2,354
Depreciation of property and equipment	150	124	445	362
Amortization of intangible assets	299	323	911	1,171
EBITDA	298	2,434	2,665	3,887
Foreign currency transaction (gains) losses on short-term intercompany balances	1,192	-574	1,079	-199
Acquisition-related charges (benefits)	'	0	'	-900
Transformation severance and related expenses	7	56	569	593
Adjusted EBITDA	1,497	1,916	4,313	3,381
Adjacent Services [Member]	'	'	'	'
Segment information	'	'	'	'
Revenue	3,586	3,625	8,150	10,705
EBIT	-265	-351	-3,607	-1,998
Depreciation of property and equipment	145	167	463	476
Amortization of intangible assets	96	183	288	547
EBITDA	-24	-1	-2,856	-975
Acquisition-related charges (benefits)	'	44	249	144
Transformation severance and related expenses	18	81	396	81
Adjusted EBITDA	-6	124	-2,211	-750
Healthcare Claims Recovery Audit Services [Member]	'	'	'	'
Segment information	'	'	'	'
Revenue	144	5,404	1,551	16,209
EBIT	-1,133	621	-4,785	1,476
Depreciation of property and equipment	22	329	176	1,093
EBITDA	-1,111	950	-4,609	2,569
Transformation severance and related expenses	26	4	431	4
Adjusted EBITDA	-1,085	954	-4,178	2,573
Corporate Support [Member]	'	'	'	'
Segment information	'	'	'	'
EBIT	-5,335	-5,694	-14,110	-15,682
EBITDA	-5,335	-5,694	-14,110	-15,682
Foreign currency transaction (gains) losses on short-term intercompany balances	-179	18	-170	2
Transformation severance and related expenses	318	'	446	'
Stock-based compensation	1,405	1,304	3,409	3,777
Adjusted EBITDA	($3,791)	($4,372)	($10,425)	($11,903)

Cash_and_Cash_Equivalents_Deta

Cash and Cash Equivalents (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
Line of Credit Facility [Line Items]	'	'
Cash and cash equivalents included short-term investments	$12.50	$24.60
Foreign Banks [Member]	'	'
Line of Credit Facility [Line Items]	'	'
Cash and cash equivalents included short-term investments	$6.40	$4.40

Debt_Details_Textual

Debt (Details Textual) (USD $)

9 Months Ended

9 Months Ended

0 Months Ended

9 Months Ended

Sep. 30, 2014

Jan. 17, 2014

Sep. 30, 2014

Jan. 19, 2010

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Aug. 07, 2014

Jun. 30, 2014

Jan. 17, 2014

Jan. 19, 2010

SunTrust Bank [Member]

Sun Trust Term Loan [Member]

Sun Trust Term Loan [Member]

Sun Trust Term Loan [Member]

Sun Trust Term Loan [Member]

Sun Trust Revolving Credit Facility [Member]

Sun Trust Revolving Credit Facility [Member]

Sun Trust Revolving Credit Facility [Member]

Sun Trust Revolving Credit Facility [Member]

Sun Trust Revolving Credit Facility [Member]

Minimum [Member]

Maximum [Member]

LIBOR [Member]

LIBOR [Member]

Line of Credit Facility [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

Four-year revolving credit and term loan agreement

'

'

19-Jan-10

'

'

'

'

'

'

'

'

'

Period of term loan and the revolving credit facility

'

'

'

'4 years

'

'

'

'

'

'

'

'

Committed revolving credit facility

'

'

'

$15,000,000

'

'

'

'

$20,000,000

'

$25,000,000

$15,000,000

Committed term loan

'

'

'

15,000,000

'

'

'

'

'

'

'

'

Frequency of payment

'

'

'Monthly

'

'Quarterly

'

'

'

'

'

'

'

Term loan required quarterly principal payments

'

'

'

'

800,000

'

'

'

'

'

'

'

First payment on the term loan

'

'

'

'

31-Mar-10

'

'

'

'

'

'

'

Term loan final principal payment

'

'

'

'

3,000,000

'

'

'

'

'

'

'

Revolving credit facility and term loan interest rate (percent)

'

1.75%

'

'

'

'

'

1.90%

'

'

'

'

Revolving credit facility outstanding

'

'

'

'

'

'

'

0

'

'

'

'

Applicable margin (percent)

'

'

'

'

'

2.25%

3.50%

1.75%

'

'

'

'

Revolving credit facility commitment fee (percent)

'

'

'

'

'

'

'

0.50%

'

'

'

'

SunTrust term loan, line of credit facility, frequency of payment

'

'

'Quarterly

'

'

'

'

'

'

'

'

'

Index rate used as reference for interest rate on revolver and term loan

'

'

'One-month LIBOR rate

'

'

'

'

'

'

'

'

'

Credit facility, covenant compliance

'The SunTrust credit facility, as amended, requires as of the end of each fiscal quarter, the Company to have achieved Consolidated Adjusted EBITDA (as defined in the agreement) of at least $18.0 million for the immediately preceding four quarters. As of June 30, 2014, the Company's Consolidated Adjusted EBITDA for the preceding four quarters was $17.0 million, and therefore the Company was not in compliance with the covenant, although there were no amounts outstanding under the credit facility as of that date. On August 7, 2014, the Company entered into an amendment of the SunTrust credit facility that provided a waiver of the non-compliance with the minimum Consolidated Adjusted EBITDA covenant for the quarter ended June 30, 2014, reduced the minimum Consolidated Adjusted EBITDA requirement to $12.0 million, modified the Fixed Charge Coverage Ratio definition for the quarter ending September 30, 2014 by excluding certain payments, and reduced the maximum borrowing amount under the senior credit facility to $20.0 million. The Company was in compliance with the covenants in its SunTrust credit facility as of September 30, 2014.

'

'

'

'

'

'

'

'

'

'

'

Credit facility, covenant for minimum adjusted EBITDA

'

'

'

'

'

'

'

'

12,000,000

18,000,000

'

'

Credit facility, covenant, adjusted EBITDA, actual

'

'

'

'

'

'

'

'

'

$17,000,000

'

'

Fair_Value_of_Financial_Instru1

Fair Value of Financial Instruments (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Bank Loan Obligations [Member]	'	'
Fair Value of Financial Instruments (Textual) [Abstract]	'	'
Fair value of long term debt	$0	'
Business Acquisition Obligations [Member]	'	'
Fair Value of Financial Instruments (Textual) [Abstract]	'	'
Fair value of long term debt	$0	$3,200,000

Income_Taxes_Details

Income Taxes (Details) (USD $)	Sep. 30, 2013
In Millions, unless otherwise specified
Income Tax Disclosure [Abstract]	'
Reversed foreign income taxes accruals	$0.50

Subsequent_Events_Details

Subsequent Events (Details) (USD $)	3 Months Ended	8 Months Ended	9 Months Ended	0 Months Ended
	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2014	Oct. 24, 2014	Oct. 01, 2014	Oct. 01, 2014
				Subsequent event [Member]	Subsequent event [Member]	Subsequent event [Member]
						Maximum [Member]
Subsequent Event [Line Items]	'	'	'	'	'	'
Proceeds from divestiture of business	'	'	'	'	$1,100,000	$900,000
Stock repurchase program, increase to authorized amount	'	'	'	20,000,000	'	'
Stock repurchase program, authorized amount	'	'	'	40,000,000	'	'
Stock repurchased during period (in shares)	1,413,017	3,100,000	3,117,277	'	'	'
Stock repurchased during period, percentage of outstanding shares	'	10.40%	'	'	'	'
Stock repurchased during period, amount	$9,000,000	$20,000,000	$20,000,000	'	'	'